- Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GRV, Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol 1984; 55:553-60.
- Cassani F, Bianchi FB, Eenzi M, Volta U, Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 1985:38:801-5.
- Powell F, Schroeter AL, Dickson ER. Antinuclear antibodies in primary biliary cirrhosis. Lancet 1984:1:288-9.
- Fritzler MJ, Valencia DV, McCarthy GA. Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 1984:27:92-6.
- Mzali S, Johanet C, Chrétien P, Abuaf N. Aiitinuclear antibodies in primary biliary cirrhosis. Gastroenterol Clin Biol 1998:3: 690-5.
- Evans .1, Reuben A, Craft .1. PBC 95k, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis. Arthritis Rheum 1991; 34:731-6.
- Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100kD nuclear protein antigen (Sp100). Clin Exp Immunol 1987:68:108-16.
- Fusconi M, Cassani F, Govoni M, Casselli A, Farabegoli F, Lernzi M, et al. Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92 kD and 96-100 kD proteins of nuclear bodies. Clin Exp Immunol 1991:83:291-7.
- Sternsdorf T, Guldner HH, Szostecki C, Grötzinger T, Will H. Two nuclear dot associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 1995:42:257-68.
- Hansen BU, Eriksson S, Lindgren S. High prevalence of autoimmune liver disease in patients with multiple nuclear dots, anti-centromere and mitotic spindle antibodies. Scand J Gastroenterol 1991:26:707-13.
- Pawlotsky JM, Andre C, Metreau JM, Beaugrand M, Zafrani ES, Dhumeaux D. Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 1992:16: 127-31.
- Zuchner D, Sternsdorf T, Szostecki C, Heathcote EJ, Cauch-Dudek K, Will H. Prevalence, kinetics and therapeutic modulation of autoantibodies against Sp 100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 1997:26:1 123-30.
- Wichmann I, Respaldiza N, Garcia-Lozano JR, Montes M, Sanchez-Roman J, Nunez-Roldán A. Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). Clin Exp Immunol 2000:119:530-2.
- Dong X, Wang J, Kabir FN, Shaw M, Reed AM, Stein L, et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000:43:85-93.
- Russo K, Hoch S, Dima C, Varga J, Teodorescu M. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erytematosus and rheumatoid arthritis. J Rheumatol 2000:27:142-8.
- Seelig HP. Autoantibodies. Peter JB, Shoenfeld Y, editors. Elsevier Science: 1996. p. 591.
- Taal BG, Schalm SW, Ten Kate Fibo WJ, Hermans J, Geertzen RGM, Feltkamp BEW. Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepato-gastroenterol 1983:30:178-82.
- Muratori P, Muratori L, Cassani F, Terlizzi P, Lenzi M, Rodrigo L, et al. Anti-multiple nuclear dots (anti-MND) and ant-Sp100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol 2002:127:172-5.
- Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Hochberg MC. Arthritis Rheum 1997:40:1725.
- Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, et al. Antimitocliondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune colangitis. Gut 1994:35:260-5.
- Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeny SJ, et al. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 1996:28:255-8.
Clinical Significance of Anti-Multiple Nuclear Dots/Sp100 Autoantibodies
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.